| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/23/2009 | US20090104190 Humanized anti-cd4 antibody with immunosuppressive properties |
| 04/23/2009 | US20090104188 Anti-hepatitis c virus antibody and uses thereof |
| 04/23/2009 | US20090104187 Novel Rabbit Antibody Humanization Methods and Humanized Rabbit Antibodies |
| 04/23/2009 | US20090104186 Melanoma-associated MHC class I associated oligopeptides and the uses thereof |
| 04/23/2009 | US20090104185 Methods and Compositions for Mycoplasma Toxins |
| 04/23/2009 | US20090104182 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 04/23/2009 | US20090104180 Using selectin/immunoglobulin fusion for quelling organ transplant rejection |
| 04/23/2009 | US20090104178 Chemokine binding activity of viral tnf receptors and related proteins |
| 04/23/2009 | US20090104177 Peptides for inhibiting the interaction of protein kinase a and protein kinase a anchor proteins |
| 04/23/2009 | US20090104155 Treatment of connective tissue disorders |
| 04/23/2009 | US20090104154 Composition and method for killing of tumours |
| 04/23/2009 | US20090104147 Sialoadhesin-Related Compositions and Methods |
| 04/23/2009 | DE102007049830A1 Neue Proteinvarianten durch zirkulare Permutation New protein variants by circular permutation |
| 04/23/2009 | CA2702998A1 Axmi-066 and axmi-076: delta-endotoxin proteins and methods for their use |
| 04/23/2009 | CA2702939A1 Anti-bst2 antibody |
| 04/23/2009 | CA2702880A1 Antibody capable of specifically binding to a beta oligomer, and use thereof |
| 04/23/2009 | CA2702856A1 Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof |
| 04/23/2009 | CA2702686A1 Translocation and mutant ros kinase in human non-small cell lung carcinoma |
| 04/23/2009 | CA2702617A1 Immunotherapy regimes dependent on apoe status |
| 04/23/2009 | CA2702592A1 Maize stress-responsive nac transcription factors and promoter and methods of use |
| 04/23/2009 | CA2702555A1 Cd19 binding agents and uses thereof |
| 04/23/2009 | CA2702039A1 Therapeutic sirna molecules for reducing vegfr1 expression in vitro and in vivo |
| 04/23/2009 | CA2701338A1 Method for production of antibody |
| 04/23/2009 | CA2701163A1 Knockout mice for a p450 gene cluster |
| 04/23/2009 | CA2701037A1 New lipophilic compositions and their uses |
| 04/23/2009 | CA2700288A1 Method for producing flu virus |
| 04/23/2009 | CA2690732A1 Rnai mediated knockdown of numa for cancer therapy |
| 04/22/2009 | EP2050825A1 Method of preparing a standard diagnostic gene transcript pattern |
| 04/22/2009 | EP2050822A1 Hepatitis C virus replicons and replicon enhanced cells |
| 04/22/2009 | EP2050821A2 Mutated D-aminotransferase and method for producing optically active glutamic acid derivatives using the same |
| 04/22/2009 | EP2050820A1 Pro-clotting enzyme, and method for detection of endotoxin or (1 3)- -d-glucan using the same |
| 04/22/2009 | EP2050819A1 Method for amplification of nucleotide sequence |
| 04/22/2009 | EP2050818A1 Transcriptional activators with graded transactivation potential |
| 04/22/2009 | EP2050817A1 Nucleic acid strand useful in detecting substance and method thereof |
| 04/22/2009 | EP2050816A1 Method for production of amino acid |
| 04/22/2009 | EP2050815A1 Streptomyces Avermitilis gene directing the ratio of B2:B1 avermectins |
| 04/22/2009 | EP2050763A2 Methods and compositions for modulating vascular integrity |
| 04/22/2009 | EP2050762A2 Novel polypeptides and nucleic acids encoding the same |
| 04/22/2009 | EP2050758A1 New polypeptides and uses thereof in cancer therapy |
| 04/22/2009 | EP2050466A1 Diagnosis and treatment of cancer using anti-desmoglein-3 antibody |
| 04/22/2009 | EP2050332A1 Application of fluorescent protein to horticultural plant |
| 04/22/2009 | EP2050036A2 Potentiation of antifungal compounds |
| 04/22/2009 | EP2049713A1 Tissue rejection |
| 04/22/2009 | EP2049691A2 Crohn disease susceptibility gene |
| 04/22/2009 | EP2049686A2 Differential labeling of cells |
| 04/22/2009 | EP2049671A1 Regulatory nucleic acid elements |
| 04/22/2009 | EP2049670A1 Production of high tryptophan maize by chloroplast targeted expression of anthranilate synthase |
| 04/22/2009 | EP2049669A2 Spore surface displays of bioactive molecules |
| 04/22/2009 | EP2049668A2 Vector systems |
| 04/22/2009 | EP2049667A2 Recombinant mycobacterium strain expressing a mycobacterial fap protein under the control of a promoter active under hypoxia and its application for cancer therapy |
| 04/22/2009 | EP2049665A2 Dinucleotide mrna cap analogs |
| 04/22/2009 | EP2049664A1 Methods and means for treating dna repeat instability associated genetic disorders |
| 04/22/2009 | EP2049565A1 Positive cytomodulines to improve bioreactor productivity. |
| 04/22/2009 | EP2049154A1 Plasmids with immunological action |
| 04/22/2009 | EP2049143A1 Improved antibacterial antisense oligonucleotide and method |
| 04/22/2009 | EP2048939A2 Transgenic plants with enhanced agronomic traits |
| 04/22/2009 | EP2002021A4 Methods for assaying protein-protein interaction |
| 04/22/2009 | EP2002007A4 Isolated luciferase gene of l. italica |
| 04/22/2009 | EP1951319A4 Chimeric immunoreceptor useful in treating human cancers |
| 04/22/2009 | EP1945764B1 Method for the isolation of mrna from formalin fixed, paraffin-embedded tissue |
| 04/22/2009 | EP1899727A4 Probe-immobilized carrier storing manufacturing condition data and manufacturing method and apparatus thereof, detecting method of target substance by use of the probe-immobilized carrier, and measuring apparatus, recording medium, kit and system for use in the detecting method |
| 04/22/2009 | EP1841866B1 Nucleic acids for apoptosis of cancer cells |
| 04/22/2009 | EP1819729B1 Method for producing carboxy-terminal amidified peptides |
| 04/22/2009 | EP1778297B1 Adeno-associated viral vector for exon skipping in a gene encoding a dispensable-domain protein |
| 04/22/2009 | EP1587476A4 Novel compositions and methods in cancer |
| 04/22/2009 | EP1578949B1 Site specific incorporation of keto amino acids into proteins |
| 04/22/2009 | EP1572968B1 Lutzomyia longipalpis polypeptides and methods of use |
| 04/22/2009 | EP1568768B1 PROTEIN BINDING TO Akt2 |
| 04/22/2009 | EP1567672B1 Expression profiling based on histocultures |
| 04/22/2009 | EP1554382B1 Gpr54 knock-out mammals and screening methods using them |
| 04/22/2009 | EP1489181B1 Dna and vector for regulating the expression of lachrymator synthase gene, method of regulating the expression of lachrymator synthase gene using the same, and plant with the regulated expression of lachrymator synthase gene |
| 04/22/2009 | EP1468014B1 Compositions and methods for WT1 specific immunotherapy |
| 04/22/2009 | EP1438437B1 Method for the detection of cytosine methylation in immobilised dna samples |
| 04/22/2009 | EP1424387B1 Method of extended culture for antigen-specific cytotoxic t lymphocytes |
| 04/22/2009 | EP1395648B1 Methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms |
| 04/22/2009 | EP1390515B1 Compositions and methods of increasing stress tolerance in plants |
| 04/22/2009 | EP1379873B1 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 04/22/2009 | EP1370696A4 Expression profiles and methods of use |
| 04/22/2009 | EP1364069B1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes |
| 04/22/2009 | EP1364057B1 Ligand detection method |
| 04/22/2009 | EP1337652B1 Manipulation of the phenolic acid content and digestibility of plant cell walls by targeted expression of genes encoding cell wall degrading enzymes |
| 04/22/2009 | EP1299727B1 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 04/22/2009 | EP1214088B1 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 04/22/2009 | EP1181319B1 Chimeric dr4 antibodies and uses thereof |
| 04/22/2009 | EP1132479B1 Protein expression vector and utilization thereof |
| 04/22/2009 | EP1114185B1 Method of isolating primer extension products with modular oligonucleotides |
| 04/22/2009 | EP1102982B1 Surfaces with reduced electroosmotic flow |
| 04/22/2009 | EP1090039B1 Peptide composition as immunogen for the treatment of allergy |
| 04/22/2009 | EP1071748A4 EXPRESSION OF $i(ALFIN1) AND METHODS FOR PRODUCING TRANSGENIC PLANTS HAVING INCREASED ROOT GROWTH AND ROOT SPECIFIC GENE ACTIVATION |
| 04/22/2009 | EP1015571B1 Rapid thermal cycle processing methods and apparatus |
| 04/22/2009 | EP0882134B1 Methods and compositions for protective and therapeutic genetic immunization |
| 04/22/2009 | EP0842948B1 ANTIFas LIGAND ANTIBODIES AND ASSAY METHOD BY USING THE SAME |
| 04/22/2009 | EP0833922B1 A novel method to isolate mutants and to clone the complementing gene |
| 04/22/2009 | EP0824585B1 Protease variants and compositions |
| 04/22/2009 | EP0736106B2 Methods of screening for beta-amyloid peptide production inhibitors |
| 04/22/2009 | EP0635068B2 Amplification of human mdm2 gene in human tumors |
| 04/22/2009 | CN101415838A Amplification of polynucleotides by rolling circle amplification |
| 04/22/2009 | CN101415829A Plants having enhanced yield-related traits and a method for making the same |
| 04/22/2009 | CN101415828A Disease-resistant plants |
| 04/22/2009 | CN101415827A Methods for generating antigen-specific effector T cells |